TAP Blocks With Ropivacaine Continuous Infusion Catheters vs Single Dose Liposomal Bupivicaine After Kidney Transplant
Clinical trial NCT03737604 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03737604
- Sponsor
- University of California, Davis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-04
- Primary completion
- 2026-09-12
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.